BENSULFOID
LOE Approachingsulfur
NDATOPICALPOWDER
Approved
Sep 1940
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
3
Data completeness
2/8 — Basic
Drug data last refreshed 17h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
BENSULFOID is a topical sulfur powder indicated for dermatological conditions, primarily acne and certain fungal or parasitic skin infections. Sulfur works through keratolytic and antimicrobial mechanisms, though exact pharmacologic class data is limited in this dataset. This is a legacy small-molecule topical treatment with decades of clinical use.
LOE Approaching
As a legacy product approaching loss of exclusivity with moderate competitive pressure (30%), commercial teams are likely small and focused on defending market position rather than expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (3)
Comparison of Topical 5% Permethrin and Topical 10% Sulfur in the Treatment of Scabies
Started Mar 2022
60 enrolled
Scabies
Safety Evaluation of IV Tc 99m Tilmanocept and Comparison of Imaging With Sulfur Colloid in Subjects With and Without NASH
Started Dec 2017
6 enrolled
Nonalcoholic SteatohepatitisNASH - Nonalcoholic Steatohepatitis
Investigations Into ISCU Myopathy or Iron Sulfur Scaffold U Protein Myopathy
Started Feb 2012
2 enrolled
Myopathy
Career Relevance
Working on BENSULFOID offers limited career advancement opportunities due to its mature, legacy status and approaching loss of exclusivity. Roles are primarily defensive/maintenance-focused rather than growth-oriented, making this a lower-priority assignment for ambitious pharma professionals.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.